Back
EyePoint Pharmaceuticals Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
64
EYPT
EyePoint Pharmaceuticals
Last Price:
9.18
Seasonality Move:
-10.5%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing slight selling pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.63 | Buy |
| 20-day SMA: | 8.68 | Buy |
| 50-day SMA: | 8.89 | Buy |
| 200-day SMA: | 16.42 | Sell |
| 8-day EMA: | 8.71 | Buy |
| 20-day EMA: | 8.63 | Buy |
| 50-day EMA: | 9.07 | Sell |
| 200-day EMA: | 12.38 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 53.32 | Buy |
| Chaikin Money Flow: | -111904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.02 - 9.02) | Buy |
| Bollinger Bands (100): | (7.51 - 12.45) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.91 while EYPT 8-day simple moving average is 8.63, which is a Buy signal.
- The stock price of EYPT is 8.91 while EyePoint Pharmaceuticals 20-day SMA is 8.68, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 8.89 while EYPT share price is 8.91, making it a Buy technically.
- EYPT stock price is 8.91 and EyePoint Pharmaceuticals 200-day simple moving average is 16.42, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
64
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $8.91. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
476.85M
Price in USD:
8.91
Share Volume:
611.17K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Buy
64
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 8.91 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.91 while EYPT 8-day exponential moving average is 8.71, which is a Buy signal.
- The stock price of EYPT is 8.91 while EyePoint Pharmaceuticals 20-day EMA is 8.63, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.07 while EYPT share price is 8.91, making it a Sell technically.
- EYPT stock price is 8.91 and EyePoint Pharmaceuticals 200-day simple moving average is 12.38, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is -0, suggesting EyePoint Pharmaceuticals is a Sell
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 53.32, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (8.02 - 9.02), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.51 - 12.45), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.